MedTrace Logo

ECMELLA vs. ECMO on 30-day Mortality

NCT05175898 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-01-04

No results posted yet for this study

Summary

This international, multicenter cohort study aims to investigate outcomes after treatment with extracorporeal cardiopulmonary resuscitation (eCPR) during cardiac arrest.

Conditions

  • Cardiac Arrest
  • Cardiopulmonary Arrest
  • Extracorporeal Membrane Oxygenation Complication
  • Cardiogenic Shock
  • Acute Myocardial Infarction

Interventions

DEVICE

VA-ECMO

Treatment with veno-arterial extracorporeal membrane oxygenation

DEVICE

ECMELLA

Treatment with veno-arterial extracorporeal membrane oxygenation plus Impella® micro-axial pump.

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Carsten Skurk, MD · Charite University

  • Tharusan Thevathasan, MD · Charite University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-28
Primary Completion
2022-10-31
Completion
2022-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05175898 on ClinicalTrials.gov